IMW 2019 | MM: BTD plus a monoclonal antibody

Amrita Krishnan

Amrita Krishnan, MD, City of Hope, Duarte, CA, outlines what was discussed at the ‘treatment of newly diagnosed myeloma transplant eligible’ plenary session she chaired at the International Myeloma Workshop (IMW) 2019, held in Boston, MA. The CASSIOPEIA study (NCT02541383) was the key point of discussion.

Share this video